Vildagliptin for Diabetes: 3 Benefits, Dosage, Side Effects

Vildagliptin, sold under the brand name Galvus, is an oral medication used to treat type 2 diabetes in adults. It belongs to a class of drugs called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). Vildagliptin helps control blood sugar levels by increasing insulin production when needed and reducing glucagon, a hormone that raises blood sugar.

About vildagliptin tablets

Vildagliptin tablets are typically white, round, and film-coated, available in 50 mg strength. They are taken orally, usually once or twice daily, with or without food. The medication is designed for long-term use to maintain glycemic control alongside diet and exercise.

Clinical studies show vildagliptin improves glucose sensitivity in pancreatic beta-cells, promoting glucose-dependent insulin secretion. This leads to reduced fasting plasma glucose (FPG), postprandial glucose (PPG), and HbA1c levels without significant risk of hypoglycemia.

Key facts about vildagliptin

• Drug class: DPP-4 inhibitor.
• Starting dose: 50 mg once daily, often increased to 50 mg twice daily.
• Time to effect: Blood sugar improvements seen within weeks; full benefits in 3-6 months.
• Common side effects: Headache, dizziness, tremor; low risk of hypoglycemia.
• Used for: Type 2 diabetes in adults, alone or with metformin, sulfonylureas, or insulin.

In a 24-week study, patients on 50 mg or 100 mg vildagliptin added to metformin saw HbA1c reductions of 0.7% and 1.0%, respectively, versus placebo, with improvements in beta-cell function.

About type 2 diabetes

Type 2 diabetes is a chronic condition where the body does not use insulin properly (insulin resistance) or produces insufficient insulin. This causes high blood sugar levels, leading to symptoms like frequent urination, thirst, fatigue, and blurred vision. Over time, it increases risks of heart disease, stroke, kidney failure, and nerve damage.

Management involves lifestyle changes (diet, exercise) and medications like metformin (first-line), followed by add-ons such as DPP-4 inhibitors like vildagliptin when control is inadequate. Early control prevents complications.

How vildagliptin works

Vildagliptin inhibits DPP-4, the enzyme that breaks down incretin hormones like GLP-1 (glucagon-like peptide-1). This prolongs incretin activity, enhancing:

• Glucose-dependent insulin secretion from beta-cells.
• Suppression of glucagon from alpha-cells, reducing liver glucose output.
• Improved beta-cell responsiveness to glucose, preserving islet function.

Unlike some diabetes drugs, vildagliptin is weight-neutral, lipid-neutral, and has a low hypoglycemia risk, making it suitable for combination therapy. Studies confirm dose-related reductions in FPG (up to 1.2 mmol/L) and PPG (up to 2.3 mmol/L) over 24 weeks.

How and when to take vildagliptin

Dosage

The usual dose is 50 mg once or twice daily. For combination with metformin, it’s often 50 mg vildagliptin/850-1000 mg metformin in fixed-dose tablets (e.g., Galvus Met) to simplify regimen.

Administration

• Swallow whole with water.
• Take with or without meals.
• If missed, take next dose as usual; do not double.
• Adjust for kidney impairment; not recommended in severe cases.

Monitor HbA1c every 3-6 months to assess efficacy.

Dosage for vildagliptin

Initial dose: 50 mg once daily. Increase to 50 mg twice daily if needed for better control. Maximum 100 mg/day. In combinations:

• With metformin: Up to 100 mg vildagliptin + maximal metformin dose.
• With sulfonylurea: Reduce sulfonylurea dose to minimize hypoglycemia.
• With insulin: Add-on yields additional HbA1c reduction without increasing hypo events.

For elderly or renal impairment (eGFR 30-50 mL/min), start at 50 mg once daily.

Who can and cannot take vildagliptin tablets

Who can take it

• Adults with type 2 diabetes uncontrolled by diet/exercise or metformin.
• Patients intolerant to metformin.
• Those needing dual therapy with sulfonylureas, thiazolidinediones, or insulin.

Who cannot take it

• Type 1 diabetes or diabetic ketoacidosis.
• Severe kidney failure (eGFR <30 mL/min).
• History of serious pancreatitis or severe liver disease.
• Pregnant or breastfeeding women (limited data).

Common questions about vildagliptin tablets

Vildagliptin is generally well-tolerated. Key points:

• Low hypoglycemia risk (1 mild event per group in trials).
• No weight gain; suitable for overweight patients.
• Combination with metformin enhances control comparably to thiazolidinediones.

Pregnancy and breastfeeding with vildagliptin tablets

Avoid during pregnancy due to lack of safety data; animal studies show no teratogenicity, but human data limited. Not recommended while breastfeeding; passes into milk. Use non-drug methods or alternatives like insulin.

Side effects of vildagliptin tablets

Most side effects are mild. Common (>1/100):

• Headache, dizziness, tremor.
• Nausea, upper abdominal pain.
• Fatigue.

Rare but serious:

• Pancreatitis (abdominal pain, vomiting).
• Hypersensitivity (rash, angioedema).
• Liver enzyme elevations; monitor LFTs.

In trials, adverse events similar to placebo; discontinuation low (2-3%).

How to cope with side effects of vildagliptin

• Headache: Rest, hydrate; paracetamol if needed.
• Dizziness: Rise slowly; avoid driving if affected.
• Tremor/nausea: Take with food; resolves usually.
• Serious symptoms: Stop and seek medical help (e.g., severe abdominal pain).

Serious side effects and when to seek medical help

Call emergency if:

• Signs of pancreatitis: severe stomach pain radiating to back.
• Allergic reaction: swelling, breathing difficulty.
• Jaundice or dark urine (liver issues).
• Persistent severe hypo (confusion, seizures) despite low risk.

Interactions with other medicines

Vildagliptin has few interactions:

• Insulin/sulfonylureas: Monitor for hypo; dose adjust.
• ACE inhibitors: Rare angioedema risk.
• Alcohol: Increases hypo risk; limit intake.
• No major CYP interactions; safe with statins, antihypertensives.

Other medicines, food and drink, and vildagliptin

No food restrictions; grapefruit ok. Avoid excessive alcohol. Inform doctor of all meds, including OTC and herbal (e.g., St. John’s wort may affect).

Driving, cycling and using machines

Vildagliptin rarely causes hypo or drowsiness. Do not drive if dizzy/hypo symptoms occur. UK law requires control to avoid penalties.

Frequently asked questions

Can I take vildagliptin on an empty stomach?

Yes, with or without food.

Does vildagliptin cause weight gain?

No, it’s weight-neutral.

Is vildagliptin safe with kidney problems?

Use caution; dose reduce in moderate impairment.

How long does vildagliptin take to work?

Effects in weeks; HbA1c drop in 3 months.

Can vildagliptin be used with insulin?

Yes, reduces HbA1c by 0.6-0.7% extra, low hypo risk.

Analgesics and NSAIDs with vildagliptin tablets

Paracetamol, ibuprofen safe; no interactions. Monitor if GI issues.

Environmental information

Vildagliptin tablets may be environmentally classified; dispose via pharmacy take-back, not wastewater.

This comprehensive guide ensures safe, effective use of vildagliptin for type 2 diabetes management, supported by clinical evidence of improved glycemic control and tolerability.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete